Total Payments
$611,502
2024 Payments
$29,982
Companies
31
Transactions
663
Payment Breakdown by Category
Other$366,976 (60.0%)
Consulting$119,757 (19.6%)
Travel$100,353 (16.4%)
Food & Beverage$18,103 (3.0%)
Research$6,313 (1.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $348,061 | 102 | 56.9% |
| Consulting Fee | $119,757 | 37 | 19.6% |
| Travel and Lodging | $100,353 | 260 | 16.4% |
| Food and Beverage | $18,103 | 245 | 3.0% |
| Honoraria | $12,715 | 6 | 2.1% |
| Unspecified | $6,313 | 11 | 1.0% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $3,200 | 1 | 0.5% |
| Compensation for serving as faculty or as a speaker for an accredited or certified continuing education program | $3,000 | 1 | 0.5% |
Payments by Type
General
$605,189
652 transactions
Research
$6,313
11 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $275,226 | 223 | $0 (2023) |
| Amgen Inc. | $88,657 | 110 | $0 (2017) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $79,610 | 69 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $49,419 | 49 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $21,868 | 37 | $0 (2023) |
| Ferring Pharmaceuticals Inc. | $14,446 | 9 | $0 (2019) |
| Janssen Scientific Affairs, LLC | $12,243 | 29 | $0 (2023) |
| Clovis Oncology, Inc. | $12,191 | 22 | $0 (2020) |
| PFIZER INC. | $11,433 | 14 | $0 (2021) |
| Curium US LLC | $6,122 | 6 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $29,982 | 31 | SUN PHARMACEUTICAL INDUSTRIES INC. ($29,579) |
| 2023 | $55,569 | 61 | Sun Pharmaceutical Industries Inc. ($32,173) |
| 2022 | $66,423 | 77 | Astellas Pharma US Inc ($28,279) |
| 2021 | $38,189 | 39 | Astellas Pharma US Inc ($26,409) |
| 2020 | $43,358 | 37 | Astellas Pharma US Inc ($24,211) |
| 2019 | $83,053 | 83 | Astellas Pharma US Inc ($41,403) |
| 2018 | $51,000 | 71 | Astellas Pharma US Inc ($39,780) |
| 2017 | $243,927 | 264 | Astellas Pharma US Inc ($101,496) |
All Payment Transactions
663 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | YONSA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,812.50 | General |
| Category: Oncology | ||||||
| 12/17/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | YONSA (Drug) | Travel and Lodging | In-kind items and services | $891.96 | General |
| Category: Oncology | ||||||
| 12/17/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | YONSA (Drug) | Travel and Lodging | In-kind items and services | $232.49 | General |
| Category: Oncology | ||||||
| 12/17/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | YONSA (Drug) | Travel and Lodging | In-kind items and services | $228.52 | General |
| Category: Oncology | ||||||
| 12/17/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | YONSA (Drug) | Food and Beverage | In-kind items and services | $121.83 | General |
| Category: Oncology | ||||||
| 11/26/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | YONSA (Drug) | Travel and Lodging | Cash or cash equivalent | $83.00 | General |
| Category: Oncology | ||||||
| 11/26/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | YONSA (Drug) | Travel and Lodging | Cash or cash equivalent | $47.19 | General |
| Category: Oncology | ||||||
| 11/26/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | YONSA (Drug) | Travel and Lodging | Cash or cash equivalent | $45.88 | General |
| Category: Oncology | ||||||
| 11/22/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $135.03 | General |
| Category: Oncology | ||||||
| 10/15/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | YONSA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,812.50 | General |
| Category: Oncology | ||||||
| 10/15/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | YONSA (Drug) | Travel and Lodging | In-kind items and services | $298.96 | General |
| Category: Oncology | ||||||
| 10/15/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | YONSA (Drug) | Travel and Lodging | In-kind items and services | $208.13 | General |
| Category: Oncology | ||||||
| 10/15/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | YONSA (Drug) | Food and Beverage | In-kind items and services | $122.08 | General |
| Category: Oncology | ||||||
| 08/26/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $29.00 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/13/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | YONSA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,937.50 | General |
| Category: Oncology | ||||||
| 05/04/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | — | Food and Beverage | In-kind items and services | $112.39 | General |
| 05/04/2024 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $34.50 | General |
| Category: Diagnostic Imaging | ||||||
| 05/02/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $26.71 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 03/28/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | YONSA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,812.00 | General |
| Category: Oncology | ||||||
| 03/28/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | YONSA (Drug) | Travel and Lodging | In-kind items and services | $661.20 | General |
| Category: Oncology | ||||||
| 03/28/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | YONSA (Drug) | Food and Beverage | In-kind items and services | $124.83 | General |
| Category: Oncology | ||||||
| 02/28/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $91.02 | General |
| Category: HORMONE THERAPY | ||||||
| 02/16/2024 | Sumitomo Pharma America, Inc. | — | Food and Beverage | In-kind items and services | $86.57 | General |
| 01/17/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | YONSA (Drug) | Travel and Lodging | In-kind items and services | $127.28 | General |
| Category: Oncology | ||||||
| 01/16/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | YONSA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,812.50 | General |
| Category: Oncology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| ENZALUTAMIDE CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $4,490 | 4 |
| Strive: A Multicenter Phase 2, Randomized, Double-blind, Efficacy And Safety Study Of Enzalutamide Vs. Bicalutamide In Men With Prostate Cancer Who Have Failed Primary Androgen Deprivation Therapy | Astellas Pharma Global Development | $1,081 | 2 |
| COMPARISON OF ENZALUTAMIDE AND BICALUTAMIDE IN PATIENTS WITH NON- | Astellas Pharma Global Development | $444.00 | 2 |
| IMPACT OF ENZALUTAMIDE ENZA VS. BICALUTAMIDE BIC ON HEALTH-R | Astellas Pharma Global Development | $184.00 | 2 |
| Impact of enzalutamide (ENZA) vs. bicalutamide (BIC) on health-related quality of life (HRQoL) of patients (pts) with castration-resistant prostate cancer (CRPC): STRIVE study | Astellas Pharma Global Development | $114.13 | 1 |
About Dr. Raoul Concepcion, MD
Dr. Raoul Concepcion, MD is a Urology healthcare provider based in Nashville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/14/2005. The National Provider Identifier (NPI) number assigned to this provider is 1104801851.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Raoul Concepcion, MD has received a total of $611,502 in payments from pharmaceutical and medical device companies, with $29,982 received in 2024. These payments were reported across 663 transactions from 31 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($348,061).
Ad
Practice Information
- Specialty Urology
- Other Specialties Urology
- Location Nashville, TN
- Active Since 12/14/2005
- Last Updated 04/14/2017
- Taxonomy Code 208800000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1104801851
Products in Payments
- Xtandi (Drug) $123,739
- XTANDI (Drug) $99,134
- XGEVA (Biological) $88,657
- YONSA (Drug) $70,158
- PROVENGE (Drug) $53,733
- Nubeqa (Drug) $15,221
- FIRMAGON (Drug) $8,613
- Odomzo (Drug) $7,783
- Xofigo (Drug) $6,430
- Rubraca (Drug) $6,393
- RUBRACA (Drug) $5,798
- ERLEADA (Drug) $5,643
- IMFINZI (Drug) $5,316
- Erleada (Drug) $4,709
- Axumin (Drug) $3,825
- FOUNDATIONACT (Device) $3,515
- ZYTIGA (Drug) $2,232
- JEVTANA (Drug) $2,193
- Enzalutamide (Drug) $1,081
- JELMYTO (Drug) $1,041
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Nashville
L Knoll, Md, MD
Urology — Payments: $2.5M
Urology $2.5M
Dr. Gautam Jayram, Md, MD
Urology — Payments: $849,729
Urology $849,729
Roger Dmochowski, Md, MD
Urology — Payments: $822,773
Urology $822,773
Dr. Ashley Tapscott, D.o, D.O
Urology — Payments: $576,883
Urology $576,883
Melissa Kaufman, Md, MD
Urology — Payments: $340,012
Urology $340,012
Dr. Benjamin Dehner, Md, MD
Urology — Payments: $184,228
Urology $184,228